Lung Small Cell Carcinoma Molecular Subtypes

general

Centers

Active Trials

$2.8B

Cancer Funding

Specific Cancer Types(2)

Name	Centers	Active Trials
Lung Small Cell Carcinoma, A Subtype	15	15
Lung Small Cell Carcinoma, I Subtype	15	15

Top Centers for Lung Small Cell Carcinoma Molecular Subtypes(15)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive	2	$472M	—
2	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	2	$452M	—
3	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	2	$319M	—
4	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive	2	$223M	—
5	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	2	$222M	—
6	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	2	$194M	—
7	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive	2	$163M	—
8	Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical	2	$153M	—
9	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive	2	$134M	—
10	University of Illinois Cancer CenterChicago, IL	2	$122M	—
11	Boston University Cancer CenterBoston, MA	2	$98M	—
12	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX	2	$83M	—
13	Cancer Center at IllinoisUrbana, IL	2	$81M	—
14	Stony Brook Cancer CenterStony Brook, NY	2	$79M	—
15	Loma Linda University Cancer CenterLoma Linda, CA	2	$10M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →